1. Please check and comment entries here.
Table of Contents

    Topic review

    Airway Inflammation

    Subjects: Physiology
    View times: 46
    Submitted by: Debanjali Dasgupta

    Definition

    The effects of airway inflammation on airway smooth muscle (ASM) are mediated by pro-inflammatory cytokines such as tumor necrosis factor alpha (TNFα).

    1. Introduction

    Airway inflammation underlies a number of pathological conditions such as asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, COVID-19 and various cough syndromes. With the COVID-19 pandemic, we are keenly aware of the detrimental impact of airway inflammation and acute respiratory distress syndrome (ARDS). Even before COVID-19, ARDS affected as many as 246,000 people in the USA each year (based on an incidence rate of ~75 per 100,000), with influenza and the common cold affecting many more. The effects of acute airway inflammation are mediated by pro-inflammatory cytokines (e.g., tumor necrosis factor alpha, TNFα) leading to increased contractile protein expression, increased force generation and increased ATP consumption in airway smooth muscle (ASM) [1][2]. In humans, the increase in ATP consumption in ASM is matched by increased mitochondrial O2 consumption at the expense of increased reactive oxygen species (ROS) formation (oxidative stress) [3]. The subsequent oxidative stress results in an accumulation of unfolded proteins in the endoplasmic reticulum (ER) and in mitochondria triggering unfolded protein responses in both organelles. In a recently published study, we demonstrated that TNFα selectively activates the inositol-requiring enzyme 1 alpha (pIRE1α) mediated ER stress pathway in human ASM, which induces alternative splicing of mRNA for the transcription factor X-box binding protein 1 (XBP1s) [3]. In a follow-up study, we showed that 24 h TNFα exposure increases the expression of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC1α) in human ASM cells, thereby promoting mitochondrial biogenesis and an increase in mitochondrial volume density [4]. The TNFα induced increase in PGC1α and mitochondrial remodeling could be downstream to either ER stress or the mitochondrial unfolded protein response (mtUPR) [5][6]. In addition to playing a key role in mitochondrial biogenesis, PGC1α also activates the Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)/Parkin mitophagy pathway, which is involved in the ubiquitination of the mitochondrial fusion protein Mfn2 [7][8]. Accordingly, we found that acute exposure to TNFα also results in a decrease in mitofusin 2 (Mfn2) protein levels in human ASM cells while expression of dynamin-related protein-1 (Drp1) increases, resulting in mitochondrial fragmentation [4][9][10]. In addition to promoting mitochondrial fusion, Mfn2 also plays an essential role in tethering mitochondria to the ER, thereby establishing the proximity of mitochondria to ER Ca2+ release sites that represent microdomains of higher cytosolic Ca2+ concentrations ([Ca2+]cyt “hotspots”) [9][10][11][12]. In another study, we reported that acute TNFα exposure disrupts the tethering of mitochondria to the ER and reduced mitochondrial Ca2+ influx through the mitochondrial Ca2+ uniporter (MCU) [13]. This is consistent with other studies showing that close proximity of mitochondria to the ER is necessary to open the MCU and thereby promote mitochondrial Ca2+ influx [9][10][11][12]. In this review article, we provide a conceptual framework for a homeostatic response triggered by activation of the pIRE1α/XBP1s ER stress pathway, which serves to mitigate the impact of TNFα-induced ER stress by promoting mitochondrial biogenesis, reducing mitochondrial Ca2+ influx and thereby limiting ROS formation (Figure 1). Components of this homeostatic response include a pIRE1α/XBP1s-mediated increase in PGC1α and an increase in PINK1/Parkin leading to: (a) a reduction in Mfn2 and restricted tethering of mitochondria to the ER, and (b) mitochondrial biogenesis leading to an increase in mitochondrial volume density, which reduces O2 consumption and ROS formation per mitochondrion, while still meet the increased ATP demand of force generation.

    Figure 1. Our conceptual model hypothesizes that, following airway inflammation, TNFα induces an increase in airway smooth muscle (ASM) force generation and ATP consumption leading to increased mitochondrial O2 consumption and reactive oxygen species (ROS) production. TNFα-induced ROS formation leads to protein unfolding and selective activation of the pIRE1α/XBP1s endoplasmic reticulum (ER) stress pathway and a mitochondrial unfolded protein response (mtUPR). Downstream XBP1s mediates an increase in PGC1α, PINK1/Parkin expression resulting in increased Drp1 and reduced Mfn2 expression, which leads to mitochondrial fragmentation and mitophagy. Reduced Mfn2 also disrupts mitochondrial tethering to the ER, thereby decreasing mitochondrial Ca2+ influx. Increased PGC1α also promotes mitochondrial biogenesis and increased mitochondrial volume density. The homeostatic remodeling of mitochondria reduces O2 consumption and ROS formation by individual mitochondrion while still meeting the increased ATP demand. Thus, the energetic load of hyper-reactivity is shared across the mitochondrial pool within ASM cells.

    2. The Homeostatic Response to TNFα in Asthmatic Human ASM

    Asthma is a chronic inflammatory condition of ASM, characterized by airway inflammation, airway hyper-contractility and airway remodeling (ASM proliferation) [14][15][16][17][18]. Surprisingly, very few studies on asthma have dealt with the crosstalk between mitochondrial oxidative stress and ER stress response and its impact on the inflammation in human ASM to date. An increased ROS generation is reported in asthmatic patients [14][19][20], which can trigger the ER stress in human ASM. Some studies have demonstrated that the activation of ER stress response in airway epithelial cells or immune cells is enhanced in asthma [21][22][23] but did not specifically explore the contribution of any of the ER stress sensor activation in this context. However, to date, no study has explored the impact of ER stress and its marker activation in human asthmatic ASM. As mentioned above, pro-inflammatory cytokine TNFα selectively induces the pIRE1α/XBP1s ER stress pathway in non-asthmatic ASM [3], and the effect of inflammation is not explored in asthmatic ASM. It is not known whether TNFα mediated ER stress plays a similar homeostatic role maintaining the dynamicity and activity of mitochondria in asthmatic conditions or if the effect is blunted. Additionally, the impact of any other proinflammatory cytokines other than TNFα in asthma is also a question to be answered. Previous studies have shown that in asthmatic ASM, mitochondrial biogenesis is increased [24][25], and we can speculate that it can be positively correlated with mitochondrial volume density, however, it has not been reported so far. We have reported an increase in mitochondrial fragmentation in human ASM of moderate asthmatics associated with an increase in mitochondrial fission protein Drp1 and a decrease in fusion protein Mfn2 expression in asthma, resulting in more fragmented mitochondrial networks [26]. Considering all the experimental evidence, further illustrating studies are needed to understand the impact of inflammation on ER stress and mitochondrial crosstalk in asthma and also to find some novel therapeutic target(s).

    3. Conclusions

    With the recent emergence of the COVID-19 pandemic, we became concerned with the pathological significance of acute airway inflammation, which is mediated by pro-inflammatory cytokines (e.g., TNFα). TNFα plays a major role in force generation and ATP consumption by ASM during airway inflammation and induces mitochondrial oxidative phosphorylation to match the increased ATP demand. As a result, ROS generation and oxidative stress is increased, which can be deleterious to the system. Simultaneously, as a homeostatic response, TNFα selectively activates the pIRE1α/XBP1s mediated ER stress pathway in ASM and increases mitochondrial biogenesis and mitochondrial volume density and reduces O2 consumption and ROS formation by individual mitochondrion and protects ASM cells from the negative impact of inflammation-induced ROS formation while still meeting the ATP demand. In our belief, a failure in this homeostatic mechanism can lead to increased ROS formation, thereby exacerbating cell death.

    This entry is adapted from 10.3390/ijms22010363

    References

    1. Dogan, M.; Han, Y.S.; Delmotte, P.; Sieck, G.C. TNFalpha enhances force generation in airway smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 2017, 312, L994–L1002.
    2. Sieck, G.C.; Dogan, M.; Young-Soo, H.; Osorio Valencia, S.; Delmotte, P. Mechanisms underlying TNFalpha-induced enhancement of force generation in airway smooth muscle. Physiol. Rep. 2019, 7, e14220.
    3. Yap, J.; Chen, X.; Delmotte, P.; Sieck, G.C. TNFα selectively activates the IRE1α/XBP1 endoplasmic reticulum stress pathway in human airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2020, 318, L483–l493.
    4. Delmotte, P.F.; Marin Mathieu, N.; Sieck, G.C. TNFα Induces Mitochondrial Fragmentation and Biogenesis in Human Airway Smooth Muscle. Am. J. Physiol. Lung. Cell Mol. Physiol. 2020.
    5. Münch, C. The different axes of the mammalian mitochondrial unfolded protein response. BMC Biol. 2018, 16, 81.
    6. Münch, C.; Harper, J.W. Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation. Nature 2016, 534, 710–713.
    7. Basso, V.; Marchesan, E.; Peggion, C.; Chakraborty, J.; von Stockum, S.; Giacomello, M.; Ottolini, D.; Debattisti, V.; Caicci, F.; Tasca, E.; et al. Regulation of ER-mitochondria contacts by Parkin via Mfn2. Pharmacol. Res. 2018, 138, 43–56.
    8. McLelland, G.L.; Goiran, T.; Yi, W.; Dorval, G.; Chen, C.X.; Lauinger, N.D.; Krahn, A.I.; Valimehr, S.; Rakovic, A.; Rouiller, I.; et al. Mfn2 ubiquitination by PINK1/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy. Elife 2018, 7, e32866.
    9. Delmotte, P.; Sieck, C.G. Interaction between endoplasmic/sarcoplasmic reticulum stress (ER/SR stress), mitochondrial signaling and Ca(2+) regulation in airway smooth muscle (ASM). Can. J. Physiol. Pharmacol. 2015, 93, 97–110.
    10. Delmotte, P.; Sieck, C.G. Endoplasmic reticulum stress and mitochondrial function in airway smooth muscle. Front. Cell Dev. Biol. 2020, 7, 374.
    11. Giacomello, M.; Drago, I.; Bortolozzi, M.; Scorzeto, M.; Gianelle, A.; Pizzo, P.; Pozzan, T. Ca2+ hot spots on the mitochondrial surface are generated by Ca2+ mobilization from stores, but not by activation of store-operated Ca2+ channels. Mol. Cell. 2010, 38, 280–290.
    12. Pallafacchina, G.; Zanin, S.; Rizzuto, R. Recent advances in the molecular mechanism of mitochondrial calcium uptake. F1000Research 2018, 7.
    13. Delmotte, P.; Zavaletta, V.A.; Thompson, M.A.; Prakash, Y.S.; Sieck, G.C. TNFalpha decreases mitochondrial movement in human airway smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 2017, 313, L166–L176.
    14. Athari, S.S. Targeting cell signaling in allergic asthma. Signal. Transduct. Target. Ther. 2019, 4, 45.
    15. Alashkar Alhamwe, B.; Miethe, S.; Pogge von Strandmann, E.; Potaczek, D.P.; Garn, H. Epigenetic regulation of airway epithelium immune functions in asthma. Front. Immunol. 2020, 11, 1747.
    16. Rosanna, D.P.; Salvatore, C. Reactive oxygen species, inflammation, and lung diseases. Curr. Pharm. Des. 2012, 18, 3889–3900.
    17. Hough, K.P.; Curtiss, M.L.; Blain, T.J.; Liu, R.M.; Trevor, J.; Deshane, J.S.; Thannickal, V.J. Airway remodeling in asthma. Front. Med. 2020, 7, 191.
    18. Zhang, J.; Dong, L. Status and prospects: Personalized treatment and biomarker for airway remodeling in asthma. J. Thorac. Dis. 2020, 12, 6090–6101.
    19. Park, S.J.; Lee, K.S.; Lee, S.J.; Kim, S.R.; Park, S.Y.; Jeon, M.S.; Lee, H.B.; Lee, Y.C. L-2-Oxothiazolidine-4-carboxylic acid or α-lipoic acid attenuates airway remodeling: Involvement of nuclear factor-κB (NF-κB), nuclear factor erythroid 2p45-related factor-2 (Nrf2), and hypoxia-inducible factor (HIF). Int. J. Mol. Sci. 2012, 13, 7915–7937.
    20. Zuo, L.; Otenbaker, N.P.; Rose, B.A.; Salisbury, K.S. Molecular mechanisms of reactive oxygen species-related pulmonary inflammation and asthma. Mol. Immunol. 2013, 56, 57–63.
    21. Kim, S.R.; Lee, Y. Endoplasmic reticulum stress and the related signaling networks in severe asthma. Allergy Asthma Immunol. Res. 2015, 7, 106–117.
    22. Jeong, J.S.; Kim, S.R.; Cho, S.H.; Lee, Y.C. Endoplasmic reticulum stress and allergic diseases. Curr. Allergy Asthma Rep. 2017, 17, 82.
    23. Pathinayake, P.S.; Hsu, A.C.; Waters, D.W.; Hansbro, P.M.; Wood, L.G.; Wark, P.A.B. Understanding the unfolded protein response in the pathogenesis of asthma. Front. Immunol. 2018, 9, 175.
    24. Girodet, P.O.; Ozier, A.; Bara, I.; Tunon de Lara, J.M.; Marthan, R.; Berger, P. Airway remodeling in asthma: New mechanisms and potential for pharmacological intervention. Pharmacol. Ther. 2011, 130, 325–337.
    25. Trian, T.; Benard, G.; Begueret, H.; Rossignol, R.; Girodet, P.O.; Ghosh, D.; Ousova, O.; Vernejoux, J.M.; Marthan, R.; Tunon-de-Lara, J.M.; et al. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. J. Exp. Med. 2007, 204, 3173–3181.
    26. Aravamudan, B.; Kiel, A.; Freeman, M.; Delmotte, P.; Thompson, M.; Vassallo, R.; Sieck, G.C.; Pabelick, C.M.; Prakash, Y.S. Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 2014, 306, L840–L854.
    More